Eam Investors, LLC Infinity Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $495,928 - $1.43 Million	840,556 New	840,556 $1 Million
Q1 2021 May 11, 2021	SELL	$1.98 - $5.36 $833,783 - $2.26 Million	-421,103 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$1.05 - $2.77 $442,158 - $1.17 Million	421,103 New	421,103 $893,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.